D. Cibula

发表

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

Z. Arık, J. Sehouli, M. Papageorgiou, 2020, Cancer medicine.

The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer

H. Kitchener, A. Teschendorff, I. Jacobs, 2012, PLoS genetics.

Hormonal contraception and risk of cancer.

C. la Vecchia, L. Dušek, M. Zikan, 2010, Human reproduction update.

Comparison of Plasma Osteopontin Levels between Patients with Borderline Ovarian Tumours and Serous Ovarian Carcinoma.

D. Cibula, M. Haluzík, J. Živný, 2016, Folia biologica.

Epigenome-based cancer risk prediction: rationale, opportunities and challenges

Andrew E. Teschendorff, Yvonne Vergouwe, Yann Joly, 2018, Nature Reviews Clinical Oncology.

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.

G. MacBeath, H. Hirte, I. Vergote, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cord blood levels of potentially neurotoxic pollutants (polychlorinated biphenyls, lead and cadmium) in the areas of Prague (Czech Republic) and Katowice (Poland). Comparison with reference values in The Netherlands. The Czech/Polish/Dutch/German Research Team.

D. Cibula, J. Zejda, V. Janoušek, 1994, Central European journal of public health.

Surgical education and training in gynecologic oncology I: European perspective.

D. Cibula, V. Kesic, 2009, Gynecologic Oncology.

Accuracy of ultrasound in prediction of rectosigmoid infiltration in epithelial ovarian cancer

L. Dušek, M. Zikan, P. Dundr, 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Prospective Evaluation of Ultrasound Accuracy in the Detection of Pelvic Carcinomatosis in Patients with Ovarian Cancer.

L. Dušek, M. Zikan, P. Dundr, 2016, Ultrasound in medicine & biology.

Follow-up in Gynecological Malignancies: A State of Art

R. Kimmig, P. Zola, T. Maggino, 2015, International Journal of Gynecologic Cancer.

Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group

L. Valentin, G. Scambia, D. Cibula, 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Imaging in gynecological disease (19): clinical and ultrasound features of extragastrointestinal stromal tumors (eGIST)

P. Dundr, D. Cibula, F. Moro, 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Ultrasound characteristics of a symptomatic and asymptomatic lymphocele after pelvic and/or paraaortic lymphadenectomy.

M. Zikan, D. Cibula, D. Fischerová, 2019, Taiwanese journal of obstetrics & gynecology.

Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study

L. Dušek, M. Zikan, P. Dundr, 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Ultrasound in Gynecological Cancer: Is It Time for Re-evaluation of Its Uses?

D. Cibula, D. Fischerová, 2015, Current Oncology Reports.

A prospective study examining the incidence of asymptomatic and symptomatic lymphoceles following lymphadenectomy in patients with gynecological cancer.

L. Dušek, M. Zikan, D. Cibula, 2015, Gynecologic oncology.

Ultrasonographic appearance of metastatic non‐gynecological pelvic tumors

M. Zikan, P. Dundr, D. Cibula, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

DNA methylation markers for early detection of women's cancer: promise and challenges.

Brigitte Rack, Martin Widschwendter, Allison Jones, 2014, Epigenomics.

A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial)

A. Weaver, B. Weigelt, A. Mariani, 2020, International Journal of Gynecological Cancer.

Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.

J. Berek, P. Sabbatini, T. Pintér, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

A. Oza, I. Bondarenko, N. Colombo, 2022, The Lancet. Oncology.

Pathologic Protocols for Sentinel Lymph Nodes Ultrastaging in Cervical Cancer.

P. Dundr, D. Cibula, M. Bártů, 2019, Archives of pathology & laboratory medicine.

DNA methylation signatures to predict the cervicovaginal microbiome status

M. Widschwendter, M. Zikan, J. Timms, 2020, Clinical epigenetics.

Challenges in lower limb lymphoedema assessment based on limb volume change: Lessons learnt from the SENTIX prospective multicentre study.

D. Cibula, S. Garrido-Mallach, D. Fischerová, 2021, Gynecologic oncology.

Is insulin resistance an essential component of PCOS?: The influence of confounding factors.

D. Cibula, D. Cibula, 2004, Human reproduction.

Myxoid mixed low-grade endometrial stromal sarcoma and smooth muscle tumor of the uterus. Case report.

M. Zikan, P. Dundr, D. Cibula, 2012, Ceskoslovenska patologie.

The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome.

D. Cibula, M. Hill, J. Vrbíková, 2001, European journal of endocrinology.

Prediction of insulin sensitivity in nonobese women with polycystic ovary syndrome.

D. Cibula, M. Hill, J. Vrbíková, 2002 .

The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.

D. Cibula, M. Hill, J. Vrbíková, 2005, Human reproduction.

Metabolic syndrome in young Czech women with polycystic ovary syndrome.

D. Cibula, M. Hill, J. Vrbíková, 2005, Human reproduction.

Insulin sensitivity in women with polycystic ovary syndrome.

D. Cibula, M. Hill, J. Vrbíková, 2004, The Journal of clinical endocrinology and metabolism.

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

R. Cífková, J. Živný, D. Cibula, 2000, Human reproduction.

Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?

J. Živný, D. Cibula, M. Hill, 2001, Human reproduction.

Pregnancy outcome in women with PCOS and in controls matched by age and weight.

D. Cibula, M. Hill, J. Živný, 2003, Human reproduction.

Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis

L. Dušek, M. Zikan, D. Cibula, 2011, Expert review of anticancer therapy.

Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey

I. Vergote, I. McNeish, G. Aravantinos, 2020, International Journal of Gynecological Cancer.

Letter to the editor, Reply to: Cecile Colpaert et al.: Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer?

D. Cibula, W. McCluggage, 2019, Gynecologic oncology reports.

Tubal ligation and the risk of ovarian cancer: review and meta-analysis.

M. Widschwendter, L. Dušek, D. Cibula, 2011, Human reproduction update.

Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review

L. Dušek, D. Cibula, O. Májek, 2015, Annals of Surgical Oncology.

Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer

G. Hanna, R. Kimmig, A. Mariani, 2021, International Journal of Gynecological Cancer.

Sentinel lymph node status in patients with locally advanced cervical cancers and impact of neoadjuvant chemotherapy.

L. Dušek, M. Zikan, P. Dundr, 2012, Gynecologic oncology.

Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer.

M. Zikan, P. Dundr, D. Cibula, 2009, Gynecologic Oncology.

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis.

J. Ledermann, S. Lheureux, A. Barnicle, 2022, Gynecologic oncology.

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial

B. Melichar, D. Cibula, J. Fucikova, 2022, Journal for ImmunoTherapy of Cancer.

Primary pure large-cell neuroendocrine carcinoma of the ovary.

P. Dundr, D. Cibula, C. Povỳsil, 2008, Pathology, research and practice.

Central Pathology Review in SENTIX, a Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)

A. Berjón, I. Vergote, P. Dundr, 2020, Cancers.

Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer.

G. Kenter, C. Meijer, L. Dušek, 2012, Gynecologic oncology.

Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis.

G. Kenter, C. Meijer, L. Dušek, 2012, Gynecologic oncology.

Response to: Correspondence on "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors" by Thomassin-Nagarra et al

D. Timmerman, I. Vergote, N. Concin, 2021, International Journal of Gynecological Cancer.

Comparative analysis of loss of heterozygosity and expression profi le in normal tissue, DCIS and invasive breast cancer

M. Zikan, D. Cibula, D. Pavlista, 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Outcomes of pregnant patients with Pap smears classified as atypical glandular cells

M. Zikan, J. Dušková, P. Dundr, 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial.

S. Marnitz, I. Vergote, D. Cibula, 2020, European journal of cancer.

Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence.

D. Cibula, M. Hill, J. Stepan, 2012, European journal of endocrinology.

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

Jae-Weon Kim, C. Schade-Brittinger, A. Reuss, 2019, The New England journal of medicine.

Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation

J. Sehouli, C. Tropé, M. Gultekin, 2013, Annals of Surgical Oncology.

Training in Bowel and Upper Abdominal Surgery in Gynaecological Oncology: European Society of Gynecological Oncology (ESGO) Statement

R. Kimmig, A. Lopes, P. Zola, 2011, International Journal of Gynecologic Cancer.

Current Clinical Practice in Cytoreductive Surgery for Advanced Ovarian Cancer: A European Survey

A. Lopes, L. Dušek, R. Verheijen, 2011, International Journal of Gynecologic Cancer.

Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer: The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO

A. Reuss, I. Vergote, J. Sehouli, 2010, International Journal of Gynecologic Cancer.

Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients

S. Marnitz, C. Köhler, D. Cibula, 2021, Cancers.

Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO)

A. Pletnev, A. Fagotti, D. Cibula, 2022, International Journal of Gynecological Cancer.

Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators

R. Jach, M. Jedryka, A. Fagotti, 2021, International Journal of Gynecological Cancer.

Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX.

L. Dušek, D. Cibula, I. Zapardiel, 2021, Gynecologic oncology.

Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer)

L. Dušek, I. Vergote, D. Cibula, 2019, International Journal of Gynecological Cancer.

Pelvic lymphadenectomy in cervical cancer--surgical anatomy and proposal for a new classification system.

D. Cibula, N. Abu-Rustum, 2010, Gynecologic oncology.

Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees.

R. Kimmig, R. Verheijen, D. Cibula, 2017, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

The Work Place Educational Climate in Gynecological Oncology Fellowships Across Europe: The Impact of Accreditation

K. Boor, N. Colombo, R. Verheijen, 2015, International Journal of Gynecologic Cancer.

Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions

P. Dundr, D. Cibula, M. Bártů, 2016, Pathology and Oncology Research.

Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin.

D. Cibula, M. Hill, J. Živný, 2002, Human reproduction.

Impaired Glucose Metabolism in Women with Polycystic Ovary Syndrome

D. Cibula, J. Vrbíková, M. Fanta, 2009, Gynecologic and Obstetric Investigation.

The best correlation of the new index of hyperandrogenism with the grade of increased body hair.

D. Cibula, M. Hill, Ľ. Stárka, 2000, European journal of endocrinology.

Extended pelvic resection for gynecological malignancies: A review of out-of-the-box surgery.

D. Cibula, G. Ferron, L. Gladieff, 2022, Gynecologic oncology.

Polycystic Ovary Syndrome: Implications for Cardiovascular, Endometrial, and Breast Disease

D. Cibula, 2004 .

Role of D327N sex hormone-binding globulin gene polymorphism in the pathogenesis of polycystic ovary syndrome

D. Cibula, M. Hill, J. Vrbíková, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival

Rebecca Hardy, Martin Widschwendter, Diana Kuh, 2014, Genome Medicine.

HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: A proof of principle study

Martin Widschwendter, Rupali Arora, Usha Menon, 2009, International journal of cancer.

Serous tubal intraepithelial carcinoma (STIC) – clinical impact and management

M. Zikan, D. Cibula, V. Weinberger, 2016, Expert review of anticancer therapy.

Steroid metabolome in fetal and maternal body fluids in human late pregnancy

D. Cibula, M. Hill, A. Pařízek, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

Novel complex genomic rearrangement of the BRCA1 gene.

M. Zikan, D. Cibula, Z. Kleibl, 2008, Mutation research.

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.

E. Kohn, V. Gebski, A. Reuss, 2022, The Lancet. Oncology.

An autologous dendritic cell vaccine promotes anticancer immunity in ovarian cancer patients with low mutational burden and cold tumors.

L. Galluzzi, J. Galon, I. Vergote, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial.

A. Hein, L. Galluzzi, B. Melichar, 2021, Gynecologic Oncology.

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

H. Putter, B. Monk, D. Provencher, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncological outcome of surgical management in patients with recurrent uterine cancer—a multicenter retrospective cohort study—CEEGOG EX01 Trial

L. Dušek, R. Jach, J. Sehouli, 2019, International Journal of Gynecological Cancer.

CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)

G. Scambia, P. Dundr, D. Cibula, 2022, International Journal of Gynecological Cancer.

SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer

P. Rolland, F. Guyon, B. Chiofalo, 2022, Annals of Surgical Oncology.

Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis.

X. Paoletti, D. Cibula, A. Feki, 2021, Gynecologic oncology.

Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery

P. Dundr, D. Cibula, D. Fischerová, 2020, British Journal of Cancer.

Management of patients with intermediate-risk early stage cervical cancer

D. Cibula, 2020, Journal of gynecologic oncology.

Oncological Outcome After Completing or Abandoning (Radical) Hysterectomy in Patients With Cervical Cancer and Intraoperative Detection of LN Positivity

D. Cibula, I. Runnebaum, Steering Commitee, 2019, Case Medical Research.

Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature.

L. Dušek, D. Cibula, K. Narayan, 2018, Gynecologic oncology.

ESGO Survey on Current Practice in the Management of Cervical Cancer

E. Åvall-Lundqvist, D. Cibula, C. Creutzberg, 2018, International Journal of Gynecologic Cancer.

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

Jae-Weon Kim, N. Colombo, G. Scambia, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SUCCOR cone study: conization before radical hysterectomy

R. Jach, M. Jedryka, A. Fagotti, 2022, International Journal of Gynecological Cancer.

European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015

A. Reuss, J. Ledermann, R. Glasspool, 2015, International Journal of Gynecologic Cancer.

Physiological Relevance of Pregnanolone Isomers and Their Polar Conjugates with Respect to the Gender, Menstrual Cycle and Pregnancy

D. Cibula, M. Hill, A. Pařízek, 2011 .

Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer

L. Dušek, P. Dundr, D. Cibula, 2020, International Journal of Gynecological Cancer.

Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions.

D. Cibula, W. McCluggage, W. McCluggage, 2019, Gynecologic oncology.

Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study.

H. Mackay, A. Oza, H. Hirte, 2012 .

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines

I. Vergote, L. Sojka, A. Coosemans, 2022, Oncoimmunology.

Relationships of circulating pregna nolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy

D. Cibula, J. Vrbíková, A. Pařízek, 2007 .

The role of androgens in determining acne severity in adult women

D. Cibula, M. Hill, J. Živný, 2000, The British journal of dermatology.

Ultrasound- guided tru- cut biopsy in the management of advanced abdomino- pelvic tumors

M. Zikan, P. Dundr, D. Cibula, 2007, International Journal of Gynecologic Cancer.

Localization of the Sentinel Node of the Upper Outer Breast Quadrant in the Axillary Quadrants

M. Zikan, D. Cibula, D. Pavlista, 2007, Annals of Surgical Oncology.

Prediction of insulin sensitivity in nonobese women with polycystic ovary syndrome.

D. Cibula, M. Hill, J. Vrbíková, 2002, The Journal of clinical endocrinology and metabolism.

Quality of life after extended pelvic exenterations.

P. Dundr, D. Cibula, M. Schneiderová, 2022, Gynecologic oncology.

DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test

M. Widschwendter, J. Dillner, U. Siebert, 2022, Clinical Epigenetics.

Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy.

D. Cibula, M. Hill, J. Vrbíková, 2007, The Journal of endocrinology.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.

R. Pötter, F. Landoni, C. Köhler, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lymphocele: prevalence and management in gynecological malignancies

M. Zikan, D. Cibula, V. Weinberger, 2014, Expert review of anticancer therapy.

Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician’s choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)

S. Pignata, N. Colombo, G. Scambia, 2021, International Journal of Gynecological Cancer.

Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy

F. Landoni, G. Scambia, A. Ayhan, 2022, Obstetrics and gynecology.

Consensus Statement on pre- operative diagnosis of ovarian tumors

T. Bourne, D. Timmerman, N. Concin, 2021 .

The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.

F. Landoni, A. Ayhan, A. Fagotti, 2021, European journal of cancer.

Pelvic floor reconstruction by modified rectus abdominis myoperitoneal (MRAM) flap after pelvic exenterations.

L. Dušek, M. Zikan, D. Cibula, 2017, Gynecologic oncology.

2017 Update on the Querleu–Morrow Classification of Radical Hysterectomy

D. Cibula, D. Querleu, N. Abu-Rustum, 2017, Annals of Surgical Oncology.

New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection.

P. Benedetti‐Panici, D. Cibula, D. Querleu, 2011, Gynecologic oncology.

Late morbidity following nerve-sparing radical hysterectomy.

M. Zikan, P. Dundr, D. Cibula, 2010, Gynecologic oncology.

Factors Affecting Spontaneous Voiding Recovery After Radical Hysterectomy

M. Zikan, D. Cibula, M. Hill, 2010, International Journal of Gynecologic Cancer.

Abdominal Radical Trachelectomy in Fertility-Sparing Treatment of Early-Stage Cervical Cancer

M. Zikan, P. Dundr, D. Cibula, 2009, International Journal of Gynecologic Cancer.

Primary Synovial Sarcoma of the Uterus

P. Dundr, D. Cibula, C. Povỳsil, 2012, Pathology & Oncology Research.

A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial

M. Zikan, D. Cibula, F. Heitz, 2014, BMC Cancer.

A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial

M. Zikan, D. Cibula, A. Reinthaller, 2014, BMC Cancer.

Abortions and contraception use among Czech and Romanian women: comparison of representative national studies.

D. Cibula, P. Weiss, V. Unzeitig, 2011, The journal of sexual medicine.

Underlying mechanisms of ovarian cancer risk reduction after tubal ligation

M. Widschwendter, L. Dušek, M. Zikan, 2011, Acta obstetricia et gynecologica Scandinavica.

Immunological configuration of ovarian carcinoma: features and impact on disease outcome

L. Galluzzi, S. Orsulic, A. Coosemans, 2021, Journal for ImmunoTherapy of Cancer.

Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents.

L. Galluzzi, D. Cibula, J. Fucikova, 2022, Trends in cancer.

Yolk Sac Tumor of the Omentum: A Case Report and Literature Review

P. Dundr, D. Cibula, D. Fischerová, 2022, Diagnostics.

International radical trachelectomy assessment: IRTA study

D. Cibula, C. Fotopoulou, B. Mosgaard, 2019, International Journal of Gynecological Cancer.

The genetic landscape of 87 ovarian germ cell tumors.

P. Neven, D. Lambrechts, I. Vergote, 2018, Gynecologic oncology.

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

H. Mackay, A. Oza, J. Barrett, 2015, The Lancet. Oncology.

Synchronous endometrioid endometrial and ovarian carcinomas are biologically related: A clinico-pathological and molecular (next generation sequencing) study of 22 cases

M. Zikan, P. Dundr, D. Cibula, 2018, Oncology letters.

Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development

Andrew E. Teschendorff, Martin Widschwendter, Allison Jones, 2013, PLoS medicine.

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma

S. Marnitz, J. Ledermann, I. Vergote, 2021, Virchows Archiv.

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

Cyrus Chargari, S. Marnitz, J. Ledermann, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Cyrus Chargari, S. Marnitz, J. Ledermann, 2020, International Journal of Gynecological Cancer.

Cancer Antigen 125: Lost to Follow-Up?

P. Zola, D. Cibula, R. Verheijen, 2012, International Journal of Gynecologic Cancer.

Women's contraceptive practices and sexual behaviour in Europe

D. Cibula, David Cibula, 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Radical Hysterectomy in Cervical Cancer

D. Cibula, 2015 .

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer

Richard Pötter, Christine Haie-Meder, Umesh Mahantshetty, 2018, International Journal of Gynecologic Cancer.

SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer

R. Jach, M. Jedryka, A. Fagotti, 2020, International Journal of Gynecological Cancer.

Pelvic Lymphadenectomy Improves Survival in Patients With Cervical Cancer With Low-Volume Disease in the Sentinel Node: A Retrospective Multicenter Cohort Study

G. Kenter, L. Dušek, M. Zikan, 2014, International Journal of Gynecologic Cancer.

A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival

A. Teschendorff, I. Jacobs, U. Menon, 2014, Genome Medicine.

[Radical parametrectomy in women with invasive cervix cancer after previous simple hysterectomy].

M. Zikan, D. Cibula, P. Marés, 2006, Ceska gynekologie.

Diagnosis, treatment, and follow-up of borderline ovarian tumors.

M. Zikan, P. Dundr, D. Cibula, 2012, The oncologist.

Subgroup analysis of rucaparib versus chemotherapy as treatment for BRCA-mutated, advanced, relapsed ovarian carcinoma: Effect of platinum sensitivity in the randomized, phase 3 study ARIEL4.

A. Oza, I. Bondarenko, N. Colombo, 2021 .

MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

B. Monk, A. Oza, I. Vergote, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma

N. Concin, J. Sehouli, A. Fagotti, 2021, International Journal of Gynecological Cancer.

Circulating levels of pregnanolone isomers during the third trimester of human pregnancy

D. Cibula, M. Hill, A. Pařízek, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Combined oral contraceptives in the treatment of polycystic ovary syndrome.

D. Cibula, J. Vrbíková, 2005, Human reproduction update.

[Initial experience with the Versapoint bipolar electrode in hysteroscopic tissue vaporization].

D. Cibula, J. Živný, H. Hrušková, 2000, Ceska gynekologie.

[Endometrial ablation].

D. Cibula, J. Živný, Z. Fučíková, 1998, Ceska gynekologie.

Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement

J. Ledermann, C. Sessa, N. Concin, 2019, International Journal of Gynecological Cancer.

An International Series on Abdominal Radical Trachelectomy: 101 Patients and 28 Pregnancies

D. Chi, D. Cibula, L. Duska, 2012, International Journal of Gynecologic Cancer.

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma

D. Cibula, J. Fucikova, I. Truxova, 2023, Journal for ImmunoTherapy of Cancer.

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

H. Putter, T. Bosse, D. Cibula, 2020, International Journal of Gynecological Cancer.

Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal and umbilical blood: 3.3β-hydroxy-5-ene steroids

D. Cibula, M. Hill, M. Meloun, 2002, The Journal of Steroid Biochemistry and Molecular Biology.

Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study

L. Dušek, P. Dundr, D. Cibula, 2020, Cancers.

SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm.

L. Dušek, M. Zikan, P. Dundr, 2018, Gynecologic oncology.

Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer.

L. Dušek, M. Zikan, P. Dundr, 2016, Gynecologic oncology.

High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer.

L. Dušek, P. Dundr, D. Cibula, 2013, Gynecologic oncology.

Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project.

F. Landoni, P. Dundr, D. Cibula, 2022, Gynecologic oncology.

A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX)

P. Dundr, D. Cibula, D. Querleu, 2019, International Journal of Gynecologic Cancer.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.

R. Pötter, F. Landoni, C. Köhler, 2018, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Sentinel lymph node biopsy in the management of gynecologic cancer

D. Cibula, N. Abu-Rustum, M. Oonk, 2015, Current opinion in obstetrics & gynecology.

Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial.

M. Zikan, S. Pudaric, P. Dundr, 2013, Gynecologic oncology.

Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer.

M. Zikan, H. Vondřichová, P. Dundr, 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Prognostic signi fi cance of low volume sentinel lymph node disease in early-stage cervical cancer ☆

G. Kenter, C. Meijer, L. Dušek, 2011 .

Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study.

P. Hillemanns, I. Vergote, G. Scambia, 2020, European journal of cancer.

Factors affecting sonographic preoperative local staging of endometrial cancer

L. Dušek, M. Zikan, P. Dundr, 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer

R. Pötter, F. Landoni, C. Köhler, 2018, International Journal of Gynecologic Cancer.

Update on abdominal radical trachelectomy.

D. Cibula, D. Fischerová, J. Sláma, 2008, Gynecologic oncology.

Laparoscopic abdominal radical trachelectomy.

D. Cibula, L. Ungár, L. Pálfalvi, 2005, Gynecologic oncology.

European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

F. Landoni, D. Cibula, C. Fotopoulou, 2020, International Journal of Gynecological Cancer.

Neuroactive steroids, their precursors, and polar conjugates during parturition and postpartum in maternal and umbilical blood: 1. identification and simultaneous determination of pregnanolone isomers

D. Cibula, M. Hill, R. Hampl, 2000, The Journal of Steroid Biochemistry and Molecular Biology.

Identification of novel HNF1B mRNA splicing variants and their qualitative and semi-quantitative profile in selected healthy and tumour tissues

P. Dundr, D. Cibula, J. Hojny, 2020, Scientific Reports.

Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock

Thomas E. Bartlett, M. Widschwendter, N. Harbeck, 2022, Genome biology.

LION: Lymphadenectomy in ovarian neoplasms—A prospective randomized AGO study group led gynecologic cancer intergroup trial.

A. Reuss, R. Kimmig, I. Vergote, 2017 .

Sexual morbidity following radical hysterectomy for cervical cancer

D. Cibula, P. Weiss, P. Vrzáčková, 2010, Expert review of anticancer therapy.

28th World Congress on Ultrasound in Obstetrics and Gynecology, 20–24 October 2018, Singapore: presentations and awards

J., Y., T., 2018, Ultrasound in Obstetrics & Gynecology.

Management of pregnancy after fertility‐sparing surgery for cervical cancer

D. Cibula, A. Pařízek, J. Sláma, 2020, Acta obstetricia et gynecologica Scandinavica.

Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery

G. Scambia, D. Cibula, N. Bizzarri, 2018, Annals of Surgical Oncology.

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.

B. Monk, I. Vergote, S. Pignata, 2021, The Lancet. Oncology.

The association among cervical, anal, and oral HPV infections in high-risk and low-risk women

L. Dušek, M. Zikan, D. Cibula, 2019, European journal of obstetrics & gynecology and reproductive biology: X.

The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.

L. Dušek, T. Zima, D. Cibula, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

526MO Pathological assessment of sentinel lymph node in early-stage cervical cancer: Results from the prospective SENTIX trial (CEEGOG-CX01; ENGOT-CX2)

D. Cibula, I. Zapardiel, T. Van Gorp, 2022, Annals of Oncology.

AGO-OVAR 28/ENGOT-ov57: Niraparib versus niraparib in combination with bevacizumab in patients with carboplatin-taxane based chemotherapy in advanced ovarian cancer—A multicenter, randomized, phase III trial.

A. Reuss, N. Colombo, D. Cibula, 2022, Journal of Clinical Oncology.

Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) + pembrolizumab (pembro) + carboplatin (carbo) ± bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC).

B. Monk, I. Vergote, J. Sehouli, 2022, Journal of Clinical Oncology.

PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study

G. Scambia, A. Fagotti, D. Cibula, 2023, International Journal of Gynecological Cancer.

Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists

A. Weaver, F. Ghezzi, A. Mariani, 2019, International Journal of Gynecologic Cancer.

Validation of ultrasound strategies to assess tumor extension and to predict high‐risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)‐4 cohort

D. Timmerman, L. Valentin, T. Van den Bosch, 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

The Diagnostic Accuracy of Ultrasound in Assessment of Myometrial Invasion in Endometrial Cancer: Subjective Assessment versus Objective Techniques

L. Dušek, M. Zikan, P. Dundr, 2017, BioMed research international.

Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey

J. Ledermann, J. Sehouli, M. Gultekin, 2019, International Journal of Gynecological Cancer.

The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership

J. Ledermann, R. Glasspool, I. Vergote, 2015, International Journal of Gynecologic Cancer.

Tisotumab vedotin (TV) + pembrolizumab (pembro) in first-line (1L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT Cx8/GOG 3024/innovaTV 205.

B. Monk, I. Vergote, S. Pignata, 2022, Journal of Clinical Oncology.

European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery

I. Vergote, C. Sessa, I. Ray-Coquard, 2016, International Journal of Gynecologic Cancer.

A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors

P. Fabián, P. Dundr, D. Cibula, 2023, Diagnostic Pathology.

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

A. Teschendorff, U. Menon, A. Ryan, 2017, Genome Medicine.

Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study

G. Scambia, K. Lindemann, D. Cibula, 2017, Annals of Surgical Oncology.

The DNA methylome of cervical cells can predict the presence of ovarian cancer

M. Widschwendter, M. Zikan, M. Kristiansen, 2022, Nature Communications.

Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.

T. Zima, T. Bosse, P. Fabián, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

The WID‐EC test for the detection and risk prediction of endometrial cancer

T. Mould, M. Widschwendter, J. Dillner, 2022, International journal of cancer.

The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers

W. Oyen, M. Bozkurt, D. Cibula, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

The association of enchondromatosis with malignant transformed chondrosarcoma and ovarian juvenile granulosa cell tumor (Ollier disease).

M. Zikan, P. Dundr, D. Cibula, 2017, Taiwanese journal of obstetrics & gynecology.

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

A. Teschendorff, U. Menon, A. Ryan, 2017, Genome Medicine.

Bone quality assessment in type 2 diabetes mellitus

D. Cibula, R. Weinstock, C. Ghosh, 2014, Osteoporosis International.

The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples

A. Ryan, M. Widschwendter, J. Dillner, 2022, Nature Communications.

Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.

A. Ryan, M. Widschwendter, M. Zikan, 2019, The Lancet. Oncology.

The polycystic ovary syndrome: the first 150 years of study

E. Adashi, D. Cibula, R. Azziz, 2022, F&S reports.

Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics.

Jiri Petrak, J. Živný, D. Cibula, 2011, Oncology reports.

Methylation patterns in serum DNA for early identification of disseminated breast cancer

U. Menon, A. Ryan, A. Gentry-Maharaj, 2017, Genome Medicine.

Correction: The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer

H. Kitchener, A. Teschendorff, I. Jacobs, 2012, PLoS Genetics.

Perspectives, Fears and Expectations of Patients with Gynaecological Cancers During the COVID-19 Pandemic: A Pan-European Study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

Z. Arık, J. Sehouli, U. Akgor, 2020, SSRN Electronic Journal.

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

F. Guyon, I. Vergote, I. Ray-Coquard, 2023, Bulletin du Cancer.

Uterine Tumors with Neuroectodermal Differentiation. A Report of 4 Cases

A. Berková, P. Dundr, D. Cibula, 2010, Pathology & Oncology Research.

Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008.

M. Babjuk, M. Ryska, T. Pavlík, 2014, Cancer epidemiology.

Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.

J. Widimský, D. Cibula, S. Svacina, 2004, The Journal of clinical endocrinology and metabolism.

Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20μg and Drospirenone 3mg

D. Cibula, U. Karck, J. Marr, 2006, Clinical drug investigation.

33 Olaparib monotherapy versus (VS) chemotherapy for germline BRCA-mutated (GBRCAM) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (PTS): phase III solo3 trial

N. Colombo, G. Scambia, D. Cibula, 2019, International Journal of Gynecological Cancer.

Olaparib monotherapy versus (vs) chemotherapy for germline BRCA-mutated (gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase III SOLO3 trial.

N. Colombo, G. Scambia, D. Cibula, 2019, Journal of Clinical Oncology.

Believable or not believable MRAM

D. Cibula, 2017, Gynecologic Oncology Reports.

Sensitivity of Follow-Up Methods in Patients After Fertility-Sparing Surgery for Cervical Cancers

L. Dušek, M. Zikan, D. Cibula, 2016, International Journal of Gynecologic Cancer.

Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience.

L. Dušek, M. Zikan, D. Cibula, 2016, Gynecologic oncology.

Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.

X. Castellsagué, D. Cibula, N. Demarteau, 2014, Vaccine.

Ten years of live surgical broadcast at Charité-MAYO conferences (2010–2019): a systematic evaluation of the surgical outcome

S. Kuemmel, I. Vergote, W. Cliby, 2022, International Journal of Gynecological Cancer.

Diagnostic Accuracy of Ultrasound and MRI in the Mapping of Deep Pelvic Endometriosis Using the International Deep Endometriosis Analysis (IDEA) Consensus

P. Dundr, D. Cibula, D. Fischerová, 2020, BioMed research international.

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

T. Bourne, D. Timmerman, N. Concin, 2021, International Journal of Gynecological Cancer.

Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women

D. Cibula, J. Vrbíková, M. Fanta, 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Comparison of corticoid substitution versus combined oral contraception administration in the treatment of non-classic adrenal hyperplasia: A prospective study

D. Cibula, M. Hill, J. Vrbíková, 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

I. Vergote, I. Ray-Coquard, B. Davidson, 2017, International Journal of Gynecologic Cancer.

Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer

M. Zikan, H. Vondřichová, P. Dundr, 2007, International Journal of Gynecologic Cancer.

Chromosomal rearrangements and their relations to histopathological and clinical parameters in epithelial ovarian cancer.

J. Dušková, D. Cibula, M. Krkavcová, 2008, Folia biologica.

Tailoring surgical treatment of cervical precancerosis.

D. Cibula, J. Sláma, M. Halaska, 2014, Ceska gynekologie.

Factors influencing decisions about surgical treatment of cervical precancerous lesions

D. Cibula, J. Sláma, B. Sehnal, 2014, Expert review of anticancer therapy.

Low-density lipoprotein receptor-related protein-5 C/T polymorphism in exon 18 is associated with C peptide and proinsulin levels in control women and patients with polycystic ovary syndrome.

D. Cibula, M. Hill, J. Vrbíková, 2008, Fertility and sterility.

Ultrasound‐guided tru‐cut biopsy of abdominal and pelvic tumors in gynecology

M. Zikan, P. Dundr, D. Cibula, 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.

D. Cibula, L. Chiva, D. Querleu, 2019, The New England journal of medicine.

Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe.

B. Monk, D. Cruickshank, M. Widschwendter, 2022, Gynecologic oncology.

ENGOT-OV44/FIRST study: a randomized, double-blind, adaptive, phase III study of standard of care (SOC) platinum-based therapy ± dostarlimab followed by niraparib ± dostarlimab maintenance as first-line (1L) treatment of stage 3 or 4 ovarian cancer (OC).

D. Provencher, R. Glasspool, B. Asselain, 2020 .

Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II

D. Provencher, D. Cruickshank, M. Widschwendter, 2019, International Journal of Gynecological Cancer.

Open Versus Minimally Invasive Radical Trachelectomy in Early-Stage Cervical Cancer: International Radical Trachelectomy Assessment Study.

B. Pitcher, D. Cibula, C. Fotopoulou, 2021, American journal of obstetrics and gynecology.

Early Learning Curve in the Assessment of Deep Pelvic Endometriosis for Ultrasound and Magnetic Resonance Imaging

P. Dundr, D. Cibula, D. Fischerová, 2020, BioMed research international.

[The factor V Leiden mutation in users of hormonal contraceptives].

D. Cibula, M. Matýšková, A. Buliková, 2000, Ceska gynekologie.

A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets

M. Widschwendter, J. Dillner, S. de Sanjosé, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

B. Monk, A. Stuckey, Zangdong He, 2023, The New England journal of medicine.

Hysteroscopic management of displaced levonorgestrel‐releasing intrauterine system

P. Dundr, D. Cibula, M. Mára, 2013, The journal of obstetrics and gynaecology research.

What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries

Felix G. Rebitschek, M. Widschwendter, O. Wegwarth, 2018, BMJ Open.

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours

T. Bourne, I. Vergote, N. Concin, 2021, Facts, views & vision in ObGyn.

Primary retroperitoneal nodal endometrioid carcinoma associated with Lynch syndrome: A case report

P. Dundr, D. Cibula, M. Vočka, 2023, Frontiers in Oncology.

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

T. Bourne, D. Timmerman, I. Vergote, 2021, International Journal of Gynecological Cancer.

Ultrasound- guided tru- cut biopsy in the management of advanced abdomino- pelvic tumors

M. Zikan, P. Dundr, D. Cibula, 2007, International Journal of Gynecologic Cancer.

SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer

R. Jach, F. Demirkıran, A. Fagotti, 2022, International Journal of Gynecological Cancer.

Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?

I. Vergote, I. Ray-Coquard, D. Cibula, 2023, Expert opinion on investigational drugs.

A Novel Perspective of Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer

D. Cibula, 2016, Annals of surgical oncology.

Microsatellite Instability in Non-Endometrioid Ovarian Epithelial Tumors: A study of 400 cases Comparing Immunohistochemistry, PCR, and NGS Based Testing with Mutation Status of MMR Genes.

T. Zima, P. Fabián, P. Dundr, 2023, Translational research : the journal of laboratory and clinical medicine.

Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer

L. Dušek, M. Zikan, P. Dundr, 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review

D. Cibula, I. Haldorsen, D. Fischerová, 2023, Cancers.

518O Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation

A. Oza, D. Cibula, K. Mclachlan, 2022, Annals of Oncology.

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

Cyrus Chargari, A. Félix, C. Centeno, 2023, International Journal of Gynecological Cancer.

Are patients and physicians willing to accept less-radical procedures for cervical cancer?

D. Cibula, K. Gungorduk, R. Kocian, 2018, Journal of gynecologic oncology.

Transrectal ultrasound (TRUS) and MRI in staging of early cervical cancer

M. Zikan, H. Vondřichová, D. Cibula, 2007 .

Surgical principles in gynecologic oncology

D. Chi, R. Bristow, D. Cibula, 2013 .

European Surgical Education and Training in Gynecologic Oncology: The impact of an Accredited Fellowship

D. Cibula, L. Chiva, A. du Bois, 2017, International Journal of Gynecologic Cancer.

Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiative

J. Ledermann, M. Gultekin, A. Strojna, 2022, International Journal of Gynecological Cancer.

Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal blood: 2. Time profiles of pregnanolone isomers

D. Cibula, M. Hill, M. Meloun, 2001, The Journal of Steroid Biochemistry and Molecular Biology.

Methylation patterns in serum DNA for early identification of disseminated breast cancer

U. Menon, A. Ryan, A. Gentry-Maharaj, 2017, Genome Medicine.

Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees

R. Kimmig, R. Verheijen, D. Cibula, 2017, International Journal of Gynecologic Cancer.

A prospective evaluation of ultrasound accuracy in the prediction of rectosigmoid infiltration in patients with epithelial ovarian cancer

Weinberger, L. Dušek, M. Zikan, 2016 .

A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations

P. Fabián, P. Dundr, D. Cibula, 2023, Diagnostic Pathology.

[Fetal fibronectin in cervico-vaginal secretions--an indicator of incipient premature labor using a membrane immunoassay].

D. Cibula, T. Peterka, J. Živný, 1995, Ceska gynekologie.

184 UPLIFT (ENGOT-ov67/GOG-3048) a pivotal cohort of upifitamab rilsodotin, a NaPi2b-directed ADC in platinum-resistant ovarian cancer

I. Ray-Coquard, N. Concin, L. Mileshkin, 2021, Ovarian cancer.

Utility and Actual Use of European and Spanish Guidelines on the Management of Endometrial Cancer Among Gynecologic Oncologists in Spain

D. Cibula, I. Zapardiel, A. Gil-Moreno, 2017, International Journal of Gynecologic Cancer.

Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion.

L. Dušek, T. Zima, D. Cibula, 2015, Neoplasma.

ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS‐CoV‐2

T. Bourne, D. Timmerman, T. Van den Bosch, 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial

M. Zikan, D. Cibula, A. Reinthaller, 2014, BMC Cancer.

High-Risk Human Papillomavirus DNA in the Primary Tumor, Sentinel, and Nonsentinel Pelvic Lymph Nodes in Patients With Early-Stage Cervical Cancer: A Correlation With Histopathology

M. Zikan, T. Zima, P. Dundr, 2009, International Journal of Gynecologic Cancer.

Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole‐body diffusion‐weighted MRI (ISAAC study)

M. Zikan, P. Dundr, D. Cibula, 2022 .

Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation

N. Concin, A. Strojna, D. Cibula, 2022, International Journal of Gynecological Cancer.

Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

P. Dundr, D. Cibula, K. Němejcová, 2015, Diagnostic Pathology.

Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance.

T. Zima, P. Fabián, P. Dundr, 2023, Pathology.

Cancer incidence and mortality in the Czech Republic.

M. Babjuk, M. Ryska, T. Pavlík, 2014, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

ENGOT-OV44/FIRST study: A randomized, double-blind, adaptive, phase III study of platinum-based therapy with dostarlimab (TSR-042) + niraparib versus standard-of-care (SOC) platinum-based therapy as first-line treatment of stage 3/4 non-mucinous epithelial ovarian cancer (OC).

D. Provencher, R. Glasspool, B. Asselain, 2019, Journal of Clinical Oncology.

ENGOT-OV43/KEYLYNK-001: A phase III, randomized, double-blind, active- and placebo-controlled study of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA-nonmutated advanced epithelial ovarian cancer.

R. Wenham, S. Lheureux, I. Vergote, 2019, Journal of Clinical Oncology.

LB001/#1731 Late-breaking abstract presentation: overall survival by number of prior lines of chemotherapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer receiving olaparib treatment or non-platinum chemotherapy in SOLO3

N. Colombo, G. Scambia, D. Cibula, 2022, Oral Abstracts (Regular and Late-Breaking Submission).

531P Maintenance olaparib monotherapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSR OC) without a germline BRCA1/BRCA2 mutation (non-gBRCAm): Final overall survival (OS) results from the OPINION trial

J. Ledermann, S. Lheureux, A. Barnicle, 2022, Annals of Oncology.

Maintenance olaparib in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by somatic (s) or germline (g) BRCA and other homologous recombination repair (HRR) gene mutation status: Overall survival (OS) results from the ORZORA study.

A. Oza, R. Glasspool, S. Pignata, 2022, Journal of Clinical Oncology.

ORZORA: Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status

A. Oza, R. Glasspool, S. Pignata, 2021, Gynecologic Oncology.

ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer.

S. Pignata, R. Coleman, N. Colombo, 2020 .

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

A. Reuss, I. Ray-Coquard, N. Colombo, 2019, International journal of cancer.

Determining post-operative morbidity and mortality following gynecological oncology surgery: protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative—GO SOAR)

D. Cibula, N. Bizzarri, P. Ramirez, 2021, International Journal of Gynecological Cancer.

A phase II randomized open-label study of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with weekly paclitaxel versus weekly paclitaxel in patients with platinum-resistant/refractory ovarian cancers.

G. MacBeath, H. Hirte, I. Vergote, 2014 .

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*

Cyrus Chargari, A. Félix, C. Centeno, 2023, Virchows Archiv.

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.

D. Timmerman, J. Ledermann, R. Glasspool, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Cancer incidence and mortality in the Czech Republic.

R Vyzula, M. Babjuk, M. Ryska, 2014, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome

D. Cibula, M. Hill, J. Vrbíková, 2007, Clinical chemistry and laboratory medicine.

Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock

Thomas E. Bartlett, M. Widschwendter, N. Harbeck, 2022, Genome Biology.

LBA30 Phase III ATALANTE/ov29 trial: Atezolizumab (Atz) versus placebo with platinum-based chemotherapy (Cx) plus bevacizumab (bev) in patients (pts) with platinum-sensitive relapse (PSR) of epithelial ovarian cancer (OC)

A. Floquet, D. Cibula, F. Heitz, 2022, Annals of Oncology.

Application of International Deep Endometriosis Analysis (IDEA) group consensus in preoperative ultrasound and magnetic resonance imaging of deep pelvic endometriosis

P. Dundr, D. Cibula, D. Fischerová, 2019, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial.

A. Oza, R. Glasspool, S. Pignata, 2023, Gynecologic oncology.

ENGOT-ov43/keylynk-001: A phase III, placebo- and active-controlled trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of advanced BRCA-nonmutated epithelial ovarian cancer

S. Lheureux, P. Zola, J. Sehouli, 2020, Gynecologic Oncology.

SUCCOR Nodes: May Sentinel Node Biopsy Determine the Need for Adjuvant Treatment?

P. Rolland, F. Guyon, B. Chiofalo, 2023, Annals of Surgical Oncology.

Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.

G. Scambia, A. Ayhan, D. Cibula, 2023, Gynecologic oncology.

Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer

D. Cibula, 2021, International Journal of Gynecological Cancer.

Early-stage intermediate-risk—the group with the most heterogenous management among patients with cervical cancer

D. Cibula, 2022, International Journal of Gynecological Cancer.

MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?

P. Dundr, D. Cibula, P. Ramirez, 2023, International Journal of Gynecological Cancer.

SUCCOR study. An international european cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 (FIGO 2009, <4 cm) cervical cancer operated in 2013–2014

F. Guyon, F. Ghezzi, R. Jach, 2019, International Journal of Gynecological Cancer.

Acute exacerbation of recurrent pelvic inflammatory disease. Laparoscopic findings in 141 women with a clinical diagnosis.

D. Cibula, J. Živný, Z. Fučíková, 2001, Journal of reproductive medicine.

Post-recurrence survival in patients with cervical cancer.

G. Scambia, A. Ayhan, D. Cibula, 2021, Gynecologic oncology.

Ovarian Cancer Screening There May Be Light at the End of the Tunnel?

D. Cibula, R. Manchanda, 2016, International Journal of Gynecologic Cancer.

HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.

P. Dundr, D. Cibula, J. Laco, 2023, Virchows Archiv.

The annual recurrence risk model for tailored surveillance strategy in 1 cervical cancer patients

Weinberger, F. Landoni, A. Ayhan, 2021 .

A comprehensive analysis of the expression, epigenetic and genetic changes of HNF1B and ECI2 in 122 cases of high-grade serous ovarian carcinoma

P. Dundr, D. Cibula, M. Bártů, 2021, Oncology letters.

KEYNOTE-C93/GOG-3064/ENGOT-en15: A phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma.

S. Pignata, N. Colombo, D. Cibula, 2022, Journal of Clinical Oncology.

Reinstatement of serum pregnanolone isomers and progesterone during alcohol detoxification therapy in premenopausal women.

D. Cibula, M. Hill, J. Vrbíková, 2005, Alcoholism, clinical and experimental research.

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

H. Mackay, A. Oza, M. Friedlander, 2015, The Lancet. Oncology.

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

I. Vergote, J. Sehouli, F. Joly, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.

B. Monk, I. Vergote, J. Sehouli, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

B. Monk, A. Oza, I. Vergote, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment

M. Widschwendter, M. Zikan, N. Colombo, 2023, NPJ precision oncology.

The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.

L. Dušek, T. Zima, D. Cibula, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis.

X. Paoletti, D. Cibula, A. Feki, 2021, Gynecologic oncology.

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

D. Cibula, I. McNeish, D. Fischerová, 2024, Annals of oncology : official journal of the European Society for Medical Oncology.

Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole‐body diffusion‐weighted MRI (ISAAC study)

M. Zikan, P. Dundr, D. Cibula, 2021, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTISS retrospective multicenter study.

G. Scambia, A. Fagotti, D. Cibula, 2022, American journal of obstetrics and gynecology.

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

B. Monk, I. Vergote, M. Zikan, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Letter to the editor, Reply to: Cecile Colpaert et al.: Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer?

D. Cibula, W. McCluggage, 2019, Gynecologic oncology reports.

LBA32 Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study

B. Monk, I. Vergote, S. Pignata, 2020 .